A detailed history of Hexagon Capital Partners LLC transactions in Baxter International Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 291 shares of BAX stock, worth $9,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
291
Previous 367 20.71%
Holding current value
$9,600
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$32.85 - $40.26 $2,496 - $3,059
-76 Reduced 20.71%
291 $11,000
Q2 2024

Jul 12, 2024

SELL
$32.87 - $43.55 $25,474 - $33,751
-775 Reduced 67.86%
367 $12,000
Q1 2024

Apr 18, 2024

BUY
$37.88 - $43.77 $7,159 - $8,272
189 Added 19.83%
1,142 $48,000
Q4 2023

Feb 05, 2024

BUY
$31.71 - $38.95 $20,326 - $24,966
641 Added 205.45%
953 $36,000
Q3 2023

Oct 23, 2023

BUY
$37.32 - $49.29 $7,352 - $9,710
197 Added 171.3%
312 $11,000
Q2 2023

Jul 24, 2023

SELL
$39.98 - $47.68 $7,196 - $8,582
-180 Reduced 61.02%
115 $5,000
Q1 2023

Apr 24, 2023

BUY
$37.58 - $52.57 $5,900 - $8,253
157 Added 113.77%
295 $11,000
Q4 2022

Jan 13, 2023

SELL
$49.7 - $57.71 $15,804 - $18,351
-318 Reduced 69.74%
138 $0
Q3 2022

Oct 17, 2022

SELL
$53.86 - $66.8 $430 - $534
-8 Reduced 1.72%
456 $25,000
Q2 2022

Jul 21, 2022

SELL
$63.83 - $80.0 $18,446 - $23,120
-289 Reduced 38.38%
464 $30,000
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $368 - $418
-5 Reduced 0.66%
753 $61,000
Q2 2021

Aug 11, 2021

BUY
$80.5 - $88.01 $2,173 - $2,376
27 Added 3.69%
758 $61,000
Q1 2021

May 13, 2021

SELL
$76.38 - $86.03 $152 - $172
-2 Reduced 0.27%
731 $61,000
Q3 2020

Nov 10, 2020

BUY
$78.33 - $90.73 $57,415 - $66,505
733 New
733 $57,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.